Uncovering the roots of Parkinson's disease, together
A global basic research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
GP2 announced the seventh data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD which includes 9,000+ additional genotyped participants.
iNDI-PD has added new cell lines associated with Parkinson’s disease variants to the Human iPSC catalog through The Jackson Laboratory (JAX). They are publicly available for the research community to use.
ASAP launched a Catalyzing Impact page and 35 impact pages for Collaborative Research Network (CRN) teams to highlight their contributions and outputs to the PD research community, along with recognition and engagement in our CRN community.
Latest News
Meeting of the (PD) Minds: Recap of the 2024 ASAP CRN Meeting
Core Leadership across the 35 CRN teams came together in person for the 2024 ASAP CRN Investigators Meeting in Rome for a week-long meeting to highlight their teams’ most impactful contributions to the PD research field since the start of their award.
Bearing down on Parkinson’s
Bloomberg News provides a deep dive into our work and our partnership with The Michael J. Fox Foundation. Working together, we’re proud to be at the forefront of Parkinson’s disease research. Click to view a PDF of the article.
Risk factor for Parkinson’s discovered in genes from people of African descent
Read NPR’s coverage of GP2’s historic GBA1 finding. This article by Jon Hamilton includes interviews with ASAP’s Managing Director, Dr. Ekemini A. U. Riley, and lead GP2 study researchers, Andy Singleton and Sara Bandres-Ciga.